Cargando…
Three dimensional model of severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain and molecular design of severe acute respiratory syndrome coronavirus helicase inhibitors
The modeling of the severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain was performed using the protein structure prediction Meta Server and the 3D Jury method for model selection, which resulted in the identification of 1JPR, 1UAA and 1W36 PDB structures as suitable templ...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kluwer Academic Publishers
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088412/ https://www.ncbi.nlm.nih.gov/pubmed/16972168 http://dx.doi.org/10.1007/s10822-006-9057-z |
_version_ | 1783509536378716160 |
---|---|
author | Hoffmann, Marcin Eitner, Krystian von Grotthuss, Marcin Rychlewski, Leszek Banachowicz, Ewa Grabarkiewicz, Tomasz Szkoda, Tomasz Kolinski, Andrzej |
author_facet | Hoffmann, Marcin Eitner, Krystian von Grotthuss, Marcin Rychlewski, Leszek Banachowicz, Ewa Grabarkiewicz, Tomasz Szkoda, Tomasz Kolinski, Andrzej |
author_sort | Hoffmann, Marcin |
collection | PubMed |
description | The modeling of the severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain was performed using the protein structure prediction Meta Server and the 3D Jury method for model selection, which resulted in the identification of 1JPR, 1UAA and 1W36 PDB structures as suitable templates for creating a full atom 3D model. This model was further utilized to design small molecules that are expected to block an ATPase catalytic pocket thus inhibit the enzymatic activity. Binding sites for various functional groups were identified in a series of molecular dynamics calculation. Their positions in the catalytic pocket were used as constraints in the Cambridge structural database search for molecules having the pharmacophores that interacted most strongly with the enzyme in a desired position. The subsequent MD simulations followed by calculations of binding energies of the designed molecules were compared to ATP identifying the most successful candidates, for likely inhibitors—molecules possessing two phosphonic acid moieties at distal ends of the molecule. |
format | Online Article Text |
id | pubmed-7088412 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Kluwer Academic Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-70884122020-03-23 Three dimensional model of severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain and molecular design of severe acute respiratory syndrome coronavirus helicase inhibitors Hoffmann, Marcin Eitner, Krystian von Grotthuss, Marcin Rychlewski, Leszek Banachowicz, Ewa Grabarkiewicz, Tomasz Szkoda, Tomasz Kolinski, Andrzej J Comput Aided Mol Des Original Paper The modeling of the severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain was performed using the protein structure prediction Meta Server and the 3D Jury method for model selection, which resulted in the identification of 1JPR, 1UAA and 1W36 PDB structures as suitable templates for creating a full atom 3D model. This model was further utilized to design small molecules that are expected to block an ATPase catalytic pocket thus inhibit the enzymatic activity. Binding sites for various functional groups were identified in a series of molecular dynamics calculation. Their positions in the catalytic pocket were used as constraints in the Cambridge structural database search for molecules having the pharmacophores that interacted most strongly with the enzyme in a desired position. The subsequent MD simulations followed by calculations of binding energies of the designed molecules were compared to ATP identifying the most successful candidates, for likely inhibitors—molecules possessing two phosphonic acid moieties at distal ends of the molecule. Kluwer Academic Publishers 2006-09-14 2006 /pmc/articles/PMC7088412/ /pubmed/16972168 http://dx.doi.org/10.1007/s10822-006-9057-z Text en © Springer Science+Business Media B.V. 2006 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Paper Hoffmann, Marcin Eitner, Krystian von Grotthuss, Marcin Rychlewski, Leszek Banachowicz, Ewa Grabarkiewicz, Tomasz Szkoda, Tomasz Kolinski, Andrzej Three dimensional model of severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain and molecular design of severe acute respiratory syndrome coronavirus helicase inhibitors |
title | Three dimensional model of severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain and molecular design of severe acute respiratory syndrome coronavirus helicase inhibitors |
title_full | Three dimensional model of severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain and molecular design of severe acute respiratory syndrome coronavirus helicase inhibitors |
title_fullStr | Three dimensional model of severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain and molecular design of severe acute respiratory syndrome coronavirus helicase inhibitors |
title_full_unstemmed | Three dimensional model of severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain and molecular design of severe acute respiratory syndrome coronavirus helicase inhibitors |
title_short | Three dimensional model of severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain and molecular design of severe acute respiratory syndrome coronavirus helicase inhibitors |
title_sort | three dimensional model of severe acute respiratory syndrome coronavirus helicase atpase catalytic domain and molecular design of severe acute respiratory syndrome coronavirus helicase inhibitors |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088412/ https://www.ncbi.nlm.nih.gov/pubmed/16972168 http://dx.doi.org/10.1007/s10822-006-9057-z |
work_keys_str_mv | AT hoffmannmarcin threedimensionalmodelofsevereacuterespiratorysyndromecoronavirushelicaseatpasecatalyticdomainandmoleculardesignofsevereacuterespiratorysyndromecoronavirushelicaseinhibitors AT eitnerkrystian threedimensionalmodelofsevereacuterespiratorysyndromecoronavirushelicaseatpasecatalyticdomainandmoleculardesignofsevereacuterespiratorysyndromecoronavirushelicaseinhibitors AT vongrotthussmarcin threedimensionalmodelofsevereacuterespiratorysyndromecoronavirushelicaseatpasecatalyticdomainandmoleculardesignofsevereacuterespiratorysyndromecoronavirushelicaseinhibitors AT rychlewskileszek threedimensionalmodelofsevereacuterespiratorysyndromecoronavirushelicaseatpasecatalyticdomainandmoleculardesignofsevereacuterespiratorysyndromecoronavirushelicaseinhibitors AT banachowiczewa threedimensionalmodelofsevereacuterespiratorysyndromecoronavirushelicaseatpasecatalyticdomainandmoleculardesignofsevereacuterespiratorysyndromecoronavirushelicaseinhibitors AT grabarkiewicztomasz threedimensionalmodelofsevereacuterespiratorysyndromecoronavirushelicaseatpasecatalyticdomainandmoleculardesignofsevereacuterespiratorysyndromecoronavirushelicaseinhibitors AT szkodatomasz threedimensionalmodelofsevereacuterespiratorysyndromecoronavirushelicaseatpasecatalyticdomainandmoleculardesignofsevereacuterespiratorysyndromecoronavirushelicaseinhibitors AT kolinskiandrzej threedimensionalmodelofsevereacuterespiratorysyndromecoronavirushelicaseatpasecatalyticdomainandmoleculardesignofsevereacuterespiratorysyndromecoronavirushelicaseinhibitors |